Tech-Enabled Biology: Pioneering a New Era in Biotechnology
The new era of full-stack compute-enabled bio companies will drive incredible advances in human health.
The new era of full-stack compute-enabled bio companies will drive incredible advances in human health.
While legacy pharma companies battle in court with government agencies over how to address the costs that result from antiquated drug development paradigms, a growing cadre of compute-enabled life science companies are unlocking the nascent power of next-generation compute technologies to transform drug discovery and development.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.